Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05053854 |
Title | PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours (PARLuNET) |
Acronym | PARLuNET |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Peter MacCallum Cancer Centre, Australia |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Peter MacCallum Cancer Centre | RECRUITING | Melbourne | Victoria | 3000 | Australia | Details |